Discover
WST
West Pharmaceutical Services, Inc.
351.37
1 x 348.13
1 x 358.22
bid
ask
-
0.76
0.22%
954 @ 04:02 PM
351.37 +0.00 (0.00%)
| Ytd | 27.71% | |
| 1y | 46.20% |
348.12
day range
354.05
223.83
52 week range
386.00
| Open | 351.05 | Prev Close | 352.13 | Low | 348.12 | High | 354.05 | Mkt Cap | 24.73B |
| Vol | 0.00 | Avg Vol | 776.79K | EPS | 7.97 | P/E | 44.09 | Forward P/E | 35.53 |
| Beta | 1.14 | Short Ratio | 2.90 | Inst. Own | 103.80% | Dividend | 0.88 | Div Yield | 0.25 |
| Ex Div Date | 07-29 | Earning | 07-23 | 50-d Avg | 342.46 | 200-d Avg | 287.32 | 1yr Est | 404.73 |
| Income Statement | |||
| Total Revenue | 872.30M | ||
| Revenues (USD) | 872.30M | ||
| Cost of Revenue | 543.10M | ||
| Gross Profit | 329.20M | ||
| Operating Expenses | 150.10M | ||
| Research and Development Expense | 19.70M | ||
| Selling, General and Administrative Expense | 117.60M | ||
| Operating Income | 179.10M | ||
| Interest Expense | 2.60M | ||
| Income Tax Expense | 32.20M | ||
| Net Income | 154.00M | ||
| Net Income Common Stock | 154.00M | ||
| Net Income Common Stock (USD) | 154.00M | ||
| Consolidated Income | 154.00M | ||
| Earnings per Basic Share | 2.17 | ||
| Earnings per Basic Share (USD) | 2.17 | ||
| Earnings per Diluted Share | 2.15 | ||
| Dividends per Basic Common Share | 0.22 | ||
| Earning Before Interest & Taxes (EBIT) | 188.80M | ||
| Earning Before Interest & Taxes (USD) | 188.80M | ||
| Weighted Average Shares | 70.80M | ||
| Weighted Average Shares Diluted | 71.30M | ||
| Balance Sheet | |||
| Cash and Equivalents | 435.80M | ||
| Cash and Equivalents (USD) | 435.80M | ||
| Investments | 207.70M | ||
| Investments Non-Current | 207.70M | ||
| Trade and Non-Trade Receivables | 712.00M | ||
| Current Assets | 1.81B | ||
| Property, Plant & Equipment Net | 1.79B | ||
| Total Assets | 4.08B | ||
| Debt Current | 20.90M | ||
| Total Debt | 312.10M | ||
| Current Liabilities | 640.50M | ||
| Debt Non-Current | 291.20M | ||
| Total Liabilities | 1.09B | ||
| Accumulated Retained Earnings (Deficit) | 4.62B | ||
| Accumulated Other Comprehensive Income | -140.40M | ||
| Shareholders Equity | 2.99B | ||
| Shareholders Equity (USD) | 2.99B | ||
| Assets Non-Current | 2.27B | ||
| Total Debt (USD) | 312.10M | ||
| Goodwill and Intangible Assets | 115.10M | ||
| Inventory | 447.40M | ||
| Liabilities Non-Current | 445.70M | ||
| Trade and Non-Trade Payables | 252.70M | ||
| Tax Assets | 72.30M | ||
| Tax Liabilities | 87.10M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 46.20M | ||
| Net Cash Flow from Financing | -164.80M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -85.60M | ||
| Capital Expenditure | -43.20M | ||
| Issuance (Purchase) of Equity Shares | -149.80M | ||
| Issuance (Repayment) of Debt Securities | -400.00K | ||
| Payment of Dividends & Other Cash Distributions | -15.70M | ||
| Net Cash Flow from Investing | -43.20M | ||
| Net Cash Flow from Operations | 124.00M | ||
| Effect of Exchange Rate Changes on Cash | -1.60M | ||
| Share Based Compensation | 10.90M | ||